Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Eye (Lond) ; 23(8): 1633-40, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19648888

ABSTRACT

BACKGROUND: Although randomized clinical trials (ANCHOR and MARINA) have shown excellent results of ranibizumab treatment in patients with neovascular age-related macular degeneration (AMD), it is unclear whether such an outcome is achievable in daily practice. We evaluated the results of ranibizumab treatment for neovascular AMD in clinical practice in Australia. METHODS: A retrospective chart review of patients in four practices injected with ranibizumab in 2006 for AMD. Patients who had been diagnosed with subfoveal choroidal neovascular membrane in the preceding 6 months and had completed at least 6 months follow-up were enrolled. No standard treatment protocols were required. The main outcome measure was visual acuity (VA) at 6 and 12 months. RESULTS: A total of 158 patients fulfilled the entry criteria. The mean baseline VA (decimal) was 0.35+/-0.21 (Snellen equivalent 6/17). At 6 months, the mean VA improved to 0.46+/-0.27 (6/13) and remained stable until month 12 (0.48+/-0.30). The improvement in VA between baseline and months 6 and 12 was statistically significant (P<0.0001). Both the mean and the median number of injections were four in the first 6 months and nine at 12 months. VA results were comparable with those of the ANCHOR and MARINA trials, and were achieved with a lower number of injections (P<0.0001). CONCLUSION: VA results achieved in daily clinical practice using ranibizumab for neovascular AMD are similar to large prospective randomized trials.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Choroidal Neovascularization/drug therapy , Immunologic Factors/therapeutic use , Macular Degeneration/drug therapy , Aged , Aged, 80 and over , Antibodies, Monoclonal, Humanized , Australia , Cohort Studies , Female , Humans , Male , Middle Aged , Randomized Controlled Trials as Topic , Ranibizumab , Retrospective Studies , Visual Acuity
3.
Br J Ophthalmol ; 89(9): 1176-9, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16113376

ABSTRACT

AIM: To determine the efficacy and safety of perfluorocarbon liquid as a short term postoperative tamponade in patients with retinal detachment from giant retinal tears. METHOD: A retrospective consecutive case series of patients with retinal detachment from giant retinal tears who underwent vitrectomy using perfluorocarbon liquid as a short term postoperative internal tamponade. The perfluorocarbon liquid was removed 5-14 days (mean 7.5 days) later and replaced by gas or silicone oil. Scleral buckling was performed in some cases with proliferative vitreoretinopathy. The crystalline lens was removed if there was interference with the surgical view or if it was subluxated. The success rate of retinal reattachment, visual outcome, and postoperative complications were assessed. RESULTS: A total of 62 eyes of 61 patients with a follow up of 8-69 months (mean 24.5 months) were included. All retinas were attached intraoperatively. 14 eyes (22.6%) developed re-detachment and additional operations were performed in 13 eyes. At final visit, 58 eyes (93.5%) had retinas that remained attached with visual acuity 6/12 or better in 27 eyes (46.5%). The visual acuity improved in 34 eyes (54.8%) with 28 eyes (45.2%) improving at least two Snellen lines, it was unchanged in 20 eyes (32.3%), and was worse in eight eyes (12.9%). Three patients developed glaucoma that was controlled medically. There was no retained perfluorocarbon liquid in any eyes. CONCLUSION: Perfluorocarbon liquid appears safe and effective to use as a short term postoperative tamponade in management of retinal detachment from giant retinal tears.


Subject(s)
Fluorocarbons/therapeutic use , Retinal Perforations/surgery , Vitrectomy/methods , Adolescent , Adult , Cataract Extraction , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Male , Middle Aged , Reoperation , Retinal Detachment/surgery , Retinal Perforations/physiopathology , Treatment Outcome , Visual Acuity
4.
J Pediatr Ophthalmol Strabismus ; 38(5): 279-83, 2001.
Article in English | MEDLINE | ID: mdl-11587176

ABSTRACT

PURPOSE: To report a series of infants who progressed from mild retinopathy of prematurity (ROP) to severe ROP with retinal detachment without demonstrating detectable threshold disease. METHODS: Between January 1993 and August 1998, seven infants at Oregon Health Sciences University, followed in accordance with the Cryotherapy for Retinopathy of Prematurity Study (CRYO-ROP) protocol, progressed to retinal detachment despite documentation that threshold had not been reached. This outlying subset of patients was analyzed and compared to the cohort in the CRYO-ROP study. RESULTS: Six of 7 patients were male, 6 (86%) patients had symmetric disease, and all patients were born outside the study hospital. Mean birth-weight was 877 g and mean gestational age was 26 weeks. Mean postconceptual age at the time of retinal detachment was 41 weeks. Because of bilateral detachment in 3 patients, the total number of study eyes is 10. Failure to achieve threshold resulted from insufficient clock hours or insufficient stage in 2 eyes and lack of plus in 8 eyes. Zone I disease was present in 1 eye. CONCLUSION: Rarely, despite adhering to ROP examination protocol, the retina may detach without demonstrating antecedent threshold disease. Very low birthweight is a factor that may lead to a less predictable course. This study found a lack of plus disease results in failure to reach threshold more often than the occurrence of insufficient clock hours of stage 3 disease. Further study is needed to determine if selected cases of subthreshold ROP may benefit from ablative therapy.


Subject(s)
Retinal Detachment/etiology , Retinopathy of Prematurity/complications , Female , Gestational Age , Humans , Infant , Infant, Newborn , Infant, Very Low Birth Weight , Male , Retinal Detachment/physiopathology , Retinopathy of Prematurity/physiopathology , Risk Factors
5.
Ophthalmology ; 107(10): 1955-9, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11013206

ABSTRACT

OBJECTIVE: We describe an unusual ocular presentation of ocular-central nervous system lymphoma in a young patient. DESIGN: Interventional case report and literature review. METHODS: A previously well 24-year-old white woman presented with left eye pain and reduced vision. Episcleral injection, globe tenderness, an afferent pupil defect, and exudative retinal detachment were present. Computed tomographic scan of the head and orbits demonstrated scleral thickening, retinal detachment, and no other abnormality. A provisional diagnosis of posterior scleritis with exudative retinal detachment was made. Investigation for underlying connective tissue diseases was negative. There was an initial prompt response to corticosteroid therapy. The patient's symptoms and signs then recurred, and a left third cranial nerve palsy developed. Systemic investigations including lumbar puncture ultimately led to the diagnosis of primary T-cell central nervous system (CNS) lymphoma. Serologic tests for human immunodeficiency virus were negative. MAIN OUTCOME MEASURES AND RESULTS: The patient underwent orbital and cranial irradiation and intrathecal and systemic chemotherapy. Despite an initial response to treatment, she returned with a recurrence of the lymphoma in the anterior segment of the left eye. Her systemic disease progressed rapidly, and she died shortly thereafter. CONCLUSIONS: This patient's young age and initial presentation mimicking posterior scleritis with unilateral exudative retinal detachment, without evidence of vitreous involvement, are highly unusual for ocular involvement in primary CNS lymphoma. A review of the literature highlights the atypical nature of this presentation.


Subject(s)
Brain Neoplasms/diagnosis , Eye Neoplasms/diagnosis , Lymphoma, T-Cell/diagnosis , Retinal Detachment/diagnosis , Scleritis/diagnosis , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Brain Neoplasms/drug therapy , Brain Neoplasms/radiotherapy , Diagnosis, Differential , Exudates and Transudates , Eye Neoplasms/drug therapy , Eye Neoplasms/radiotherapy , Fatal Outcome , Female , Fluorescein Angiography , Humans , Injections, Spinal , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/radiotherapy , Magnetic Resonance Imaging , Neoplasm Recurrence, Local , Oculomotor Nerve Diseases/diagnosis , Visual Acuity
6.
Aust N Z J Ophthalmol ; 22(3): 155-9; discussion 153, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7818872

ABSTRACT

Reflexes are an essential part of protective and homeostatic function, both in general terms and with specific reference to ocular structures. A wide range of stimuli and responses, with varying degrees of central processing, is involved in such reflexes. The simplest reflexes are monosynaptic, such as the stretch or myotatic reflex. More complex polysynaptic reflexes are involved in many regulatory and protective functions--these include autonomic as well as somatic reflexes. Ocular autonomic reflexes include the oculocardiac, pupillary, accommodative and lacrimatory reflexes. Ocular somatic reflexes include eyelid and extra-ocular muscle reflexes (such as Bell's phenomenon, vestibulo-ocular and optokinetic reflexes). An account of the above reflexes is given in the format of an essay, modified from the FRACO Part I Examination in Physiology. The topic was 'Discuss reflex activities with particular reference to the eye'. The content is based on several of the texts recommended for the Part I Examination, as listed under references.


Subject(s)
Ocular Physiological Phenomena , Reflex/physiology , Blinking/physiology , Humans , Oculomotor Muscles/physiology , Reflex, Monosynaptic/physiology , Reflex, Oculocardiac/physiology , Reflex, Pupillary/physiology , Reflex, Vestibulo-Ocular/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...